Cargando…

Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study

INTRODUCTION: Blood coagulation constituents might exert immunomodulatory functions in the CNS and may trigger neuroinflammation and demyelination. We evaluated whether particular single-nucleotide polymorphisms (SNPs), thought to be involved in fibrinogen-mediated hemostatic pathways, are overrepre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbadessa, Gianmarco, Miele, Giuseppina, Di Pietro, Andrea, Sparaco, Maddalena, Palladino, Raffaele, Armetta, Ignazio, D’Elia, Giovanna, Trojsi, Francesca, Signoriello, Elisabetta, Lus, Giacomo, Lavorgna, Luigi, Bonavita, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918146/ https://www.ncbi.nlm.nih.gov/pubmed/34561786 http://dx.doi.org/10.1007/s10072-021-05608-1

Ejemplares similares

Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Disability assessment using Google Maps
por: Lavorgna, Luigi, et al.
Publicado: (2021)

Correction to: Disability assessment using Google Maps
por: Lavorgna, Luigi, et al.
Publicado: (2021)

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study †
por: Miele, Giuseppina, et al.
Publicado: (2023)

Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series
por: Abbadessa, Gianmarco, et al.
Publicado: (2022)

Viral pericarditis following ocrelizumab in a multiple sclerosis patient
por: Miele, Giuseppina, et al.
Publicado: (2023)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

Emotional facial palsy: an unusual and rarely explored neurological sign
por: Miele, Giuseppina, et al.
Publicado: (2022)

Telemedicine application to headache: a critical review
por: Spina, Emanuele, et al.
Publicado: (2022)

Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
por: Signoriello, Elisabetta, et al.
Publicado: (2023)

Digital work engagement among Italian neurologists
por: Brigo, Francesco, et al.
Publicado: (2021)

Public Engagement and Neurology: An Update
por: Lavorgna, Luigi, et al.
Publicado: (2021)

Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021)

Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report
por: Abbadessa, Gianmarco, et al.
Publicado: (2019)

Apparently isolated CNS involvement in Erdheim-Chester disease: Case report
por: Romano, Giuseppe, et al.
Publicado: (2023)

The Role of Wearable Devices in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2018)

Digital therapeutics in neurology
por: Abbadessa, G., et al.
Publicado: (2021)

How to manage with telemedicine people with neuromuscular diseases?
por: Spina, Emanuele, et al.
Publicado: (2021)

Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
por: Lanzillo, Roberta, et al.
Publicado: (2022)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
por: Zanghì, Aurora, et al.
Publicado: (2022)

Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response
por: Mallardo, Marta, et al.
Publicado: (2023)

Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology
por: Abbadessa, Gianmarco, et al.
Publicado: (2023)

Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Nociplastic Pain in Multiple Sclerosis Spasticity: Dermatomal Evaluation, Treatment with Intradermal Saline Injection and Outcomes Assessed by 3D Gait Analysis: Review and a Case Report
por: De Blasiis, Paolo, et al.
Publicado: (2022)

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery
por: Moccia, Marcello, et al.
Publicado: (2019)

The Use of Social Media and Digital Devices Among Italian Neurologists
por: Lavorgna, Luigi, et al.
Publicado: (2020)

Bilateral foot-drop secondary to demyelinating neuropathy post-COVID-19 infection: A case report
por: Maida, Elisabetta, et al.
Publicado: (2021)

Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions—A Systematic Review
por: Sharbafshaaer, Minoo, et al.
Publicado: (2023)

Whole-Brain Propagation Delays in Multiple Sclerosis, a Combined Tractography-Magnetoencephalography Study
por: Sorrentino, P., et al.
Publicado: (2022)

Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2023)

Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease
por: Signoriello, Elisabetta, et al.
Publicado: (2021)

Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease
por: Signoriello, Elisabetta, et al.
Publicado: (2021)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
por: Petracca, Maria, et al.
Publicado: (2022)

Integrated Cognitive Rehabilitation Home-Based Protocol to Improve Cognitive Functions in Multiple Sclerosis Patients: A Randomized Controlled Study
por: Sharbafshaaer, Minoo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vd5vaea77bahq970r344mtqrlr